CB2 Insights announced it is entering the Colombian market to advance medical cannabis research efforts within the country. The focus is to build Colombia's patient registry and grow the country's physician network using CB2's proprietary artificial intelligence based Decision Support Tool and CB2's Sail, the industry's first Clinical Trial Data Management System.

To achieve these goals, CB2 has appointed Dr. Paola Cubillos, MD, a prominent Colombian naturopathic and integrative medicine physician, as the Company's Medical Director in Colombia. Dr. Cubillos was trained and has practiced in both Toronto, Canada and Colombia. Fusing both conventional and naturopathic treatments, she has spearheaded several medical cannabis research efforts at Clinica Las Americas, a highly recognized private hospital in Colombia that belongs to one of the largest healthcare networks in Latin America. Dr. Cubillos has been at the forefront of medical cannabis advancements and physician perception and education throughout Colombia and Latin America.